Attenuated and vectored vaccines protect nonhuman primates against Chikungunya virus
2017 · JCI Insight · 107 citations
https://doi.org/10.1172/jci.insight.83527
D
David Hallengärd
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
34
Papers
1.1K
Citations
17
h-index
22
i10-index
David Hallengärd is an academic researcher from Karolinska Institutet. The author has contributed to research in topics: HIV Research and Treatment & Immunotherapy and Immune Responses & Transgenic Plants and Applications. The author has an h-index of 17, co-authored 29 publications.
Papers by this author
worksA combination of intradermal jet-injection and electroporation overcomes in vivodose restriction of DNA vaccines
2012 · Genetic Vaccines and Therapy · 30 citations
https://doi.org/10.1186/1479-0556-10-5
Rational design of HIV vaccines and microbicides: report of the EUROPRISE network annual conference 2010
2011 · Journal of Translational Medicine · 23 citations
https://doi.org/10.1186/1479-5876-9-40
Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference
2010 · Journal of Translational Medicine · 10 citations
https://doi.org/10.1186/1479-5876-8-72
Erratum to: Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference
2010 · Journal of Translational Medicine · 1 citations
https://doi.org/10.1186/1479-5876-8-82
P19-29. Determining the optimal protocol for plasmid DNA vaccine delivery by intradermal in vivo electroporation
2009 · Retrovirology · 0 citations
https://doi.org/10.1186/1742-4690-6-s3-p349
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat